Use of cadaveric fascia lata allograft for pubovaginal slings

The pubovaginal sling has become a favored treatment option for stress urinary incontinence (SUI). While initially indicated for treating SUI secondary to intrinsic sphincter deficiency, it has proven versatile for the management of urethral hypermobility (type 2 incontinence) (1). Originally introduced by Giordano (2) in 1907, the concept of suburethral support was reintroduced in 1978 by McGuire and Lytton (3). This work described successful results using autologous rectus fascia for sling construction and set the stage for ongoing exploration into sling materials and techniques to minimize morbidity, operative time, and time of recovery. Many options are available, and the quest for a gold standard continues.